EdwardVincentLoftusJr.MDFACP, FACG, AGAF

PubMed

• 1 citations
  Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease.
  Abhinav Vasudevan, Laura H Raffals, David H Bruining, Michelle Becker, Mohammad Hassan Murad, Vivek Tharayil, Edward V Loftus Jr> ;Inflammatory Bowel Diseases. 2024 Apr 3
• Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
  Tanita Suttichaimongkol, Edward V Loftus Jr> ;Inflammatory Bowel Diseases. 2024 Apr 3
• The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel Disease.
  Siri A Urquhart, Bryce P Comstock, Mauricio F Jin, Courtney N Day, John E Eaton, William S Harmsen, Laura E Raffals, Nayantara Coelho-Prabhu, Edward V Loftus Jr> ;Inflammatory Bowel Diseases. 2024 Feb 1
• Home-based Biologic Infusions for Inflammatory Bowel Disease: Are We Ready for Prime Time?
  Raseen Tariq, Edward V Loftus> ;Inflammatory Bowel Diseases. 2023 Oct 11
• 4 citations
  Novel Therapies for Patients With Inflammatory Bowel Disease.
  Priscila Santiago, Manuel B Braga-Neto, Edward V Loftus> ;Gastroenterology & Hepatology. 2022 Aug 1
• 11 citations
  Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
  Gary R Lichtenstein, Brian Bressler, Carlos Francisconi, Severine Vermeire, Nervin Lawendy, Leonardo Salese, Gosford Sawyerr, Hongjiong Shi, Chinyu Su, Donna T Judd, T...> ;Inflammatory Bowel Diseases. 2023 Jan 5
• 62 citations
  Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, rando...
  Bruce E Sands, Peter M Irving, Timothy Hoops, James L Izanec, Long-Long Gao, Christopher Gasink, Andrew Greenspan, Matthieu Allez, Silvio Danese, Stephen B Hanauer, Vi...> ;Lancet. 2022 Jun 11
• 67 citations
  Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, with...
  Marc Ferrante, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean-Frederic Colombel, Silvio Danese, Marla Dubinsky, Brian G Feagan, Tadakazu Hisamatsu, Allen Lim, James...> ;Lancet. 2022 May 28
• 86 citations
  Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
  Geert D'Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean-Frederic Colombel, Silvio Danese, Marla Dubinsky, Brian G Feagan, Tadakazu Hisamatsu, Allen Lim, James...> ;Lancet. 2022 May 28
• 178 citations
  Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
  Bruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus Jr, Silvio Danese, Jean-Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raq...> ;The New England Journal of Medicine. 2019 Sep 26
• 3 citations
  Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase ...
  Julian Panés, Edward V Loftus, Peter D R Higgins, James O Lindsay, Wen Zhou, Xuan Yao, Dapo Ilo, Charles Phillips, Jacinda Tran, Yuri Sanchez Gonzalez, Séverine Vermeire> ;Inflammatory Bowel Diseases. 2023 Sep 1
• Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to Conclude.
  Edward V Loftus Jr, Stephàne Paul, Xavier Roblin> ;Clinical Gastroenterology and Hepatology. 2023 Aug 1
• 17 citations
  The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries.
  Satimai Aniwan, Priscila Santiago, Edward V Loftus Jr, Sang Hyoung Park> ;United European Gastroenterology Journal. 2022 Dec 1
• 1 citations
  Endoscopic Bariatric Therapies for the Management of Obesity in Patients with Inflammatory Bowel Disease.
  Amanda M Johnson, Andrew C Storm, Tala Mahmoud, Rabih Ghazi, Babusai Rapaka, Donna M Abboud, Edward V Loftus Jr, Barham K Abu Dayyeh> ;Obesity Surgery. 2023 Feb 1
• 3 citations
  Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis.
  Vipul Jairath, Russell D Cohen, Edward V Loftus Jr, Ninfa Candela, Karen Lasch, Bob G Schultz> ;BMC Gastroenterology. 2022 Dec 6
• 17 citations
  Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.
  Edward V Loftus Jr, Jean-Frederic Colombel, Ken Takeuchi, Xiang Gao, Remo Panaccione, Silvio Danese, Marla Dubinsky, Stefan Schreiber, Dapo Ilo, Tricia Finney-Hayward,...> ;Clinical Gastroenterology and Hepatology. 2023 Aug 1
• 12 citations
  The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
  Amanda M Johnson, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati, Vipul Jairath, Neeraj Narula, Farhad Peerani, Benjamin H Click, Elliot S Coburn, ThucNh...> ;The American Journal of Gastroenterology. 2023 Feb 1
• 1 citations
  Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease.
  Daniela Guerrero Vinsard, David H Bruining, James E East, Derek Ebner, Sunanda V Kane, John B Kisiel, Jonathan A Leighton, Ryan J Lennon, Edward V Loftus Jr, Talha Mal...> ;Gastrointestinal Endoscopy. 2023 Apr 1
• 5 citations
  Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease.
  Rishika Chugh, Manuel B Braga-Neto, Thomas W Fredrick, Guilherme P Ramos, Jonathan Terdiman, Najwa El-Nachef, Edward V Loftus, Uma Mahadevan, Sunanda V Kane> ;Journal of Crohn's & Colitis. 2023 Apr 19
• 1 citations
  Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
  Laurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, Wan-Ju Lee, Jenny Griffith, Kori Wallace, Sofie Berg, Xiaomei Liao, Julian Panes, Edward V Loftus Jr, Edouard Louis> ;Alimentary Pharmacology & Therapeutics. 2023 Mar 1
• Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes.
  Zeinab Bakhshi, Siddhant Yadav, W Scott Harmsen, Jithinraj Edakkanambeth Varayil, Kevin A Karls, William J Tremaine, Edward V Loftus> ;Inflammatory Bowel Diseases. 2023 Aug 1
• 11 citations
  Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank.
  Quazim A Alayo, Edward V Loftus Jr, Andres Yarur, David Alvarado, Matthew A Ciorba, Lisa de Las Fuentes, Parakkal Deepak> ;Clinical Gastroenterology and Hepatology. 2023 Mar 1
• 2 citations
  Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study.
  Edward V Loftus, Séverine Vermeire, Brian G Feagan, Franck-Olivier Le Brun, Alessandra Oortwijn, Ulrik Moerch, William J Sandborn, Toshifumi Hibi> ;Journal of Crohn's & Colitis. 2023 Mar 18
• 9 citations
  Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial.
  Silvio Danese, Marc Ferrante, Brian G Feagan, Laurent Peyrin-Biroulet, Toshifumi Hibi, William J Sandborn, Stefan Schreiber, Timothy Ritter, Edward V Loftus Jr, Gerhar...> ;The American Journal of Gastroenterology. 2023 Jan 1
• 2 citations
  A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease.
  Varun P Moktan, Nader D Daoud, William J Tremaine, Edward V Loftus Jr, Sunanda V Kane, Alexander P Hochwald, David O Hodge, Jana G Hashash, Stephanie S Faubion, Franci...> ;Crohn's & Colitis 360. 2022 Jul 1
• Join now to see all

Journal Articles

• Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
  Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
• Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus  
  Edward V Loftus, Edward V Loftus, David Schwartz, David Schwartz, Inflammatory Bowel Diseases
• Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  
  Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
• Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients with Crohn’s Disease with up to 6 Years of Follow-up in the Pyramid Registry  
  Edward V Loftus, Roopal Thakkar, Nature
• Outcomes of Endoscopic Therapy for Luminal Strictures in Crohn’s Disease  
  John Kisiel, Edward V Loftus, David H Bruining, Raina Shivashankar, Inflammatory Bowel Diseases
• Co-existent pulmonary granulomatosis with polyangiitis (Wegener's) and Crohn's disease  
  Vaszar LT, Orzechowski NM, Specks U, Ytterberg SR, Loftus EV Jr, Mark EJ, Tazelaar HD, Am J Surg Pathol, 3/1/2014
• Designing a national inflammatory bowel disease surveillance program  
  Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan G, Bernstein C, Colombel JF, Walker A, Herrinton L, Velayos F, Loftus EV Jr et al, Inflamm Bowel Dis, 2/1/2014
• A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease  
  Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV Jr, Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel..., Inflamm Bowel Dis, 8/1/2013
• Incidence of Spondyloarthropathy in patients with ulcerative colitis: a population-based study  
  Shivashankar R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Matteson EL, J Rheumatol, 7/1/2013
• Inflammatory bowel disease: diagnosis and therapeutics Cohen RD (Book Review)  
  Loftus EV, Gastroenterology, 1/1/2012
• Direct costs of diverticulitis in a US managed care population  
  Yen L, Davis KL, Hodgkins P, Loftus EV Jr, Haim Erder M, American Journal of Pharmacy Benefits, 1/1/2012
• Development of the Crohn's disease digestive damage score, the Lemann score  
  Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, Chowers Y, D'Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV et al, Inflamm Bowel Dis, 6/1/2011
• Commentary  
  Loftus EV Jr, Gastroenterol Hepatol, 1/1/2011
• Clinical updates on the use of biologic agents in patients with Crohn's disease  
  Loftus EV, Gastroenterol Hepatol, 1/1/2010
• Overview: Commentary  
  Loftus EV Jr, Gastroenterol Hepatol, 1/1/2010
• Perioperative anti-tumornecrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease  
  Nasir BS, Dozois EJ, Cima RP, Pemberton JH, Wolff BG, Sandborn WJ, Loftus EV, Larson DW, J Gastrointest Surg, 1/1/2010
• Ultrasound-enteroclysis for Crohn's disease: The best of both worlds?  
  Bruining DH, Loftus EV, Inflamm Bowel Dis, 2/1/2008
• Examining patient populations across clinical trials of biologics  
  Loftus EV, Gastroenterol Hepatol, 1/1/2008
• Certolizumab pegol reduces symptoms in patients with moderately to severely active Crohn's disease - Commentary  
  Loftus EV Jr, Evidence-Based Gastroenterol, 1/1/2008
• Optimizing biologic therapies in the treatment of Crohn's disease: Commentary  
  Loftus EV, Gastroenterol Hepatol, 1/1/2008
• Clinical trials in biologic therapy for Crohn's disease: Comparing designs and data  
  Lichtenstein GR, Hanauer SB, Loftus EV Jr, Gastroenterol Hepatol, 1/1/2008
• Epidemiology of microscopic colitis - Authors' response  
  Pardi DS, Loftus EV, Melton LJ, Zinsmeister AR, Gut, 7/1/2007
• Maximizing compliance and efficacy in the use of 5-ASA formulations for ulcerative colitis: Commentary  
  Loftus EV, Gastroenterol Hepatol, 1/1/2007
• The risk of colorectal cancer in ulcerative colitis in a population-based setting - Reply  
  Jess T, Loftus EV, Gastroenterology, 8/1/2006
• Contemporary management of ulcerative colitis: the patient's perspective  
  Loftus EV, Kane SV, Lichtensetein GR, Sandborn WJ, Gastroenterology & Hepatology, 1/1/2006
• Join now to see all

Books/Book Chapters

• GI Epidemiology: Diseases and Clinical Methodology. 
  Chapter: Epidemiology of Inflammatory Bowel Disease. 
  Page 273 - 284Talley NJ, Locke GR III, Moayyedi P, West J, Ford AC, Saito YAWiley, West Sussex, UKEdition 2nd,2014
• Curbside Consultation in IBD: 49 Clinical Questions. 
  Chapter: What is the best medical therapy for IBD in the elderly? Are anti-TNFs safe in the patient population? 
  Friedman RD, Farraye FSLACK, Inc.Edition 2nd,2013
• Clinical challenges and complications of IBD. 
  Chapter: Hepatobiliary Disease. 
  Page 175 - 194Regueiro MD, Swoger JMSLACK, Thorofare, NJ2013
• Crohn's disease and ulcerative colitis: from epidemiology and immunobiology to a rational diagnostic and therapeutic approach. 
  Chapter: Conventional medical management of ulcerative colitis: azathioprine. 
  Page 473 - 480Levesque BG, Loftus EVEditors: Baumgart DC.Springer, New York, NY2012
• Pocket Guide to IBD 2. 
  Chapter: Osteoporosis. 
  Page 157 - 163Dubinsky M, Friedman SSLACK, Thorofare, NJEdition 2nd,2011
• Advanced Therapy in Inflammatory Bowel Disease. 
  Chapter: CT enterography and other small bowel imaging. 
  Page 185 - 188Bayless TM, Hanauer SBPeople's Medical Publishing House, SheltonEdition 3rd,2011
• Ulcerative colitis: the complete guide to medical management. 
  Chapter: Management of refractory ulcerative colitis. 
  Page 319 - 330:Lichtenstein GR, Scherl EJSLACK, Thorofare, NJ2011
• Advanced Therapy in Inflammatory Bowel Disease. 
  Chapter: Metabolic bone disease in IBD patients: prevention and treatment. 
  Page 549 - 553Bayless TM, Hanauer SBPeople's Medical Publishing House, SheltonEdition 3rd,2011
• Inflammatory bowel disease. Translating basic science into clinical practice. 
  Chapter: Imaging in inflammatory bowel disease: computed tomography and magnetic resonance enterography, ultrasound and enteroscopy. 
  Page 266 - 278Targan SR, Shanahan F, Karp LCWiley-Blackwell, West Sussex, UK2010
• Chronic inflammation of liver and gut: Falk Symposium 163. 
  Chapter: Can we predict the natural history of ulcerative colitis? 
  Page 38 - 45Adler G, Jia JD, Fau DM, LaRusso N, Owyang CEditors: Adler G, Jia JD, Fau DM, LaRusso N, Owyang C.Springer, Dordrecht, Netherlands2009
• Curbside consultation in IBD: 49 clinical questions. 
  Chapter: What is the role of computed tomographic enterography in the diagnosis and management of inflammatory bowel disease? Has it replaced barium radiography? 
  Page 93 - 95Rubin DT, Friedman S, Farraye FASLACK, Thorofare, NJ2009
• Shackelford's surgery of the alimentary tract. 
  Chapter: Inflammatory bowel disease. 
  Page 2080 - 2100Yeo CJSaunders, Philadelphia, PAEdition 6th,2007
• Colitis: diagnosis and therapeutic strategies: Falk Symposium 147. 
  Chapter: Azathioprine: long-term side effects. 
  Page 142 - 151Loftus EVEditors: Jewell DP, Colombel JF, Pena AS, Tromm A, Warren BF.Springer, Dordrecht, Netherlands2006
• Mayo Clinic medical manual. 
  Chapter: Inflammatory bowel disease. 
  Page 641 - 652Loftus CG, Loftus EV JrEditors: Oliveira GHM, Nesbitt GC, Murphy JG.Mayo Clinic Scientific Press, Taylor & Francis Group, Boca Raton, FL2006
• GI epidemiology. 
  Chapter: Inflammatory bowel disease. 
  Page 198 - 206Loftus EV JrEditors: Talley NJ, Locke GR III, Saito YA.Blackwell, Malden, MA2006
• Pocket guide to inflammatory bowel disease. 
  Chapter: Osteoporosis. 
  Page 116 - 123Loftus EVEditors: Kane SV, Dubinsky MC.Cambridge University Press2005
• Mayo Clinic gastroenterology and hepatology board review. 
  Chapter: Inflammatory bowel disease: extraintestinal manifestations and cancer. 
  Page 195 - 2000Loftus EV JrEditors: Hauser SC.Mayo Clinic Scientific Press, Rochester, MN2004
• Kirsner's inflammatory bowel disease. 
  Chapter: Epidemiology of inflammatory bowel diseases. 
  Page 245 - 262Sandler RS, Loftus EV JrEditors: Sartor RB, Sandborn WJ.Saunders, Edinburgh, ScotlandEdition 6th,2004
• Self-assessment color review of gastroentology. 
  Chapter: Contributor of test questions and endoscopic photographs. 
  Loftus EVEditors: Gilinsky NH, Forbes A.Lippincott Williams and Wilkins, Philadelphia, PA1999
• Internal medicine. 
  Chapter: Diseases of small bowel absorption. 
  Page 2056 - 2068Charlton MR, Loftus EVJrEditors: Stein JH.Mosby, St. Louis, MO1998
• Advances in pancreatic disease: molecular biology, diagnosis and treatment. 
  Chapter: The spectrum of cystic neoplasms of the pancreas including mucinous ductal ectasia. 
  Page 352 - 370Sarr MG, Prabhakar LP, Loftus EVEditors: Dervenis CG.Georg Thieme Verlag, Stuttgart, Germany1996
• Join now to see all

Abstracts/Posters

• Biomarkers of neoplasm in ulcerative colitis.
  Garrity-Park M, Loftus E, Smyrk T, Inflamm Bowel Dis, 12/1/2013
• Osteonecrosis in inflammatory bowel disease: clinical features and outcomes.
  Yadav S, Loftus E, Tremaine W, Edakkanambeth Varayil J, Karls K, Inflamm Bowel Dis, 12/1/2013
• Histologic features of small bowel adenocarcinomas in Crohn's disease.
  Weber N, Smyrk T, Bruining D, Fletcher J, Fidler J, Pardi D, Loftus E, Inflamm Bowel Dis, 12/1/2013
• PYRAMID registry: an observational study of adalimumab in Crohn's disease: results at year 5.
  D'Haens G, Reinisch W, Satsangi J, Loftus E, Panaccione R, Castillo M, Kan-Dobrosky N, Eichner S, Thakkar R, Inflamm Bowel Dis, 12/1/2013
• Objectifying the Crohn's disease activity index (cdai): can we teach an old score new tricks?
  Morris M, Stewart S, Sandborn W, Loftus E, Fowler S, Jones J, Am J Gastroenterol, 10/1/2013
• Cumulative incidence of cancer in a population-based cohort of inflammatory bowel disease.
  Yadav S, Singh S, Edakkanambeth Varayil J, Tremaine W, Loftus E, Am J Gastroenterol, 10/1/2013
• Prevalence and outcomes of colonic serrated epithelial changes in patients with ulcerative colitis and Crohn's colitis.
  Johnson D, Khanna S, Smyrk O, Loftus E, Anderson K, Mahoney D, Ahlquist D, Kisiel J, Am J Gastroenterol, 10/1/2013
• Long-term effectiveness of adalimumab in Crohn's disease: observational data from the pyramid registry.
  Loftus E, D'Haen G, Reinisch W, Satsangi J, Panaccione R, Thakkar R, Eichner S, Castillo M, Kan-Dobrosky N, Skup M, Chao JD, Mulani P, Am J Gastroenterol, 10/1/2013
• A meta-analysis of risk of lymphoma in ibd patients: a comparison between patients actively using thiopurines and those with past use.
  Kotlyar D, Lewis J, Tierney A, Brensinger C, Beaugerie L, Loftus E, Blonski W, Van Domselaar M, Chaparro M, Sandilya S, Lichtenstein G, Am J Gastroenterol, 10/1/2013
• Clinical features and outcomes in patients with inflammatory bowel disease and concomitant sarcoidosis.
  Shahi V, Khanna S, Loftus E, Am J Gastroenterol, 10/1/2013
• Rising incidence of ischemic colitis in Olmsted County, Minnesota, 1976-2006: a population-based epidemiological study.
  Dave M, Siddhant Y, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sweetser SR, Locke GR, Loftus EV, Gastroenterology, 5/1/2013
• Risk of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.
  Singh S, Edakkanambeth Varayil J, Loftus E, Talwalkar J, Am J Gastroenterol, 1/1/2013
• Risk factors and outcomes of ischemic colitis in a population-based cohort.
  Yadav S, Dave M, Edakkanambeth Varayil J, Harmsen W, Tremaine W, Zinsmeister A, Sweetser S, Locke G, Sandborn W, Loftus E, Am J Gastroenterol, 1/1/2013
• Rate and predictors of possible missed esophageal and gastric cancers after esophagogastroduodenoscopy in the United States.
  Wang Y, Loftus E, Judge T, Peikin S, Am J Gastroenterol, 1/1/2013
• PYRAMID Registry: an observational study of adalimumab in Crohn's disease: results at year five.
  D'Haens G, Reinisch W, Satsangi J, Loftus E, Panaccione R, Castillo M, Kan-Dobrosky N, Eischner S, Thakkar R, Am J Gastroenterol, 1/1/2013
• Outcomes from fecal microbiota transplantation in adults with C.
  Khanna S, Kashyap P, Rainey J, Kammer P, Loftus E, Pardi D, Am J Gastroenterol, 1/1/2013
• Objectifying the Crohn's disease Crohn's Disease Activity Index (CDAI): can we teach an old score new tricks?
  Morris M, Stewart S, Sandborn W, Loftus E, Fowler S, Jones J, Am J Gastroenterol, 1/1/2013
• Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systemic review and meta-analysis.
  Singh S, Singh H, Loftus E, Pardi D, Am J Gastroenterol, 1/1/2013
• Intestinal wall remodeling on CT enterography may not predict improved bone health.
  Weber N, Fidler J, Clarke B, Khosla S, Fletcher J, Keaveny T, Lee D, Pardi D, Loftus E, Kane S, Barlow J, Bruining D, Am J Gastroenterol, 1/1/2013
• Inflammatory bowel disease does not impact mortality but increases length of hospitalization in patients with acute myocardial infarction.
  Dave M, Mehta K, Badheka D, Loftus E, Am J Gastroenterol, 1/1/2013
• Frequency of vitamin D testing and deficiency in Crohn's disease: a population-based study.
  Shivashankar R, Tremaine W, Harmsen W, Zinsmeister A, Loftus E, Am J Gastroenterol, 1/1/2013
• High levels of non-clonal serum immunoglobulin free light chains as biomarker of chronic inflammatory gastrointestinal disorders.
  Allen A, Thorneau T, Kim WR, Dispenzieri A, Kyle R, Loftus E, Roberts L, Rajkumar V, Am J Gastroenterol, 1/1/2013
• A predictive model incorporating clinical and endoscopic features for diagnosing Cytomegalovirus colitis in patients with inflammatory bowel disease.
  McCurdy J, Jones A, Loftus E, Bruining D, Enders F, Killian J, Smyrk T, Am J Gastroenterol, 1/1/2013
• Patients with inflammatory bowel disease co-infected with Clostridium difficile and Cytomegalovirus: rates of hospitalization and colectomy.
  McCurdy J, Jones A, Khanna S, Enders F, Killian J, Thapa P, Smyrk T, Bruining D, Loftus E, Am J Gastroenterol, 1/1/2013
• De novo Non-Skin Malignancy Risk After Liver Transplantation for Primary Sclerosing Cholangitis.
  Singh S, Talwalkar J, Watt KD, Loftus EV, Hay JE, Poterucha JJ, Charlton MR, Rosen CB, Heimbach JK, Wiesner R, Gastroenterology, 1/1/2013
• Join now to see all

Lectures

• What Causes IBD? 
  Lincolnshire, IL - 5/1/2014
• New Therapies for Inflammatory Bowel Disease. 
  Denver, CO - 4/1/2014
• The Newest Research Findings: New Medications for Crohn's and Colitis. 
  Atlanta, GA - 3/1/2014
• Optimizing Biologic Therapy: Maximizing Benefit and Minimizing Risk. 
  Atlanta, GA - 3/1/2014
• Malignancy in IBD: When to Suspect? 
  Kochi, India - 2/1/2014
• Environmental Factors-Research in IBD. 
  Kochi, India - 2/1/2014
• Isolated Periappendiceal Inflammation in UC. 
  Kochi, India - 2/1/2014
• Biologicals in Crohn's disease: Is that the final answer now. 
  Kochi, India - 2/1/2014
• Other Major Side Effects Due to Immunomodulators and/or Biologics in Our IBD Patients. 
  Hollywood, FL - 12/1/2013
• Pro: Immunomodulators Must Be Stopped When a Viral, Bacterial, or Fungal Infection Occurs. 
  Hollywood, FL - 12/1/2013
• Current and Evolving Treatment Paradigms in IBD. 
  Bismarck, ND - 11/1/2013
• Optimal Use of Immunomodulators and Biologics. 
  San Diego, CA - 10/1/2013
• Practical Applications of Effective Disease Monitoring: The Concept of "Tight Control". 
  San Diego, CA - 10/1/2013
• Inflammatory Bowel Disease and Intestinal Disorders. 
  Berlin, Germany - 10/1/2013
• IBD Epidemiology State of the Art. 
  Berlin, Germany - 10/1/2013
• Epidemiology of IBD: What's New. 
  Boston, MA - 9/1/2013
• Current and Future Treatment Paradigms of Inflammatory Bowel Disease. 
  Chicago, IL - 5/1/2013
• Continued Surveillance Should be Recommended for Low-Grade Dysplasia. 
  Philadelphia, PA - 3/1/2013
• Imaging in IBD: Alternatives to Routine CT Scans (MRI, Capsule, Deep Enteroscopy, Low-dose CT). 
  Philadelphia, PA - 3/1/2013
• New Therapies Update. 
  Bloomington, MN - 3/1/2013
• Challenges in Studying the Natural History of IBD. 
  Seattle, WA - 3/1/2013
• Descriptive Epidemiology of a Regional Longitudinal Cohort: the Olmsted County Experience. 
  2/1/2013
• Epidemiologic Research in IBD: Designing a Surveillance Program for IBD in the United States. 
  Philadelphia, PA - 2/1/2013
• The Role of Biologics in Crohn's Disease. 
  Scottsdale, Arizona - 2/1/2013
• Perianal Crohn's Disease. 
  Scottsdale, Arizona - 2/1/2013
• Join now to see all

Other

• Safety of TNF antagonists in Crohn's disease. 
  Loftus EV
  http://www.medscape.com/viewarticle/552616
  1/1/2007